Cigarette Smokers Versus Cousers of Cannabis and Cigarettes: Exposure to Toxicants.


Journal

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
ISSN: 1469-994X
Titre abrégé: Nicotine Tob Res
Pays: England
ID NLM: 9815751

Informations de publication

Date de publication:
16 07 2020
Historique:
received: 31 05 2019
accepted: 11 10 2019
pubmed: 17 10 2019
medline: 24 11 2020
entrez: 17 10 2019
Statut: ppublish

Résumé

Cannabis and tobacco couse is common and could expose users to higher levels of toxicants. No studies have examined biomarkers of toxicant exposure in cousers of cannabis and cigarettes, compared with cigarette smokers (CS). Adult daily CS were recruited from 10 US sites for a study of reduced nicotine cigarettes. In this analysis of baseline data, participants were categorized as either cousers of cannabis and tobacco (cousers; N = 167; urine positive for 11-nor-9-carboxy-Δ 9-tetrahydrocannnabinol and self-reported cannabis use ≥1×/week), or CS (N = 911; negative urine and no self-reported cannabis use). Participants who did not meet either definition (N = 172) were excluded. Self-reported tobacco and cannabis use and tobacco and/or combustion-related biomarkers of exposure were compared between groups. Compared to CS, cousers were younger (couser Mage = 38.96, SD = 13.01; CS Mage = 47.22, SD = 12.72; p < .001) and more likely to be male (cousers = 67.7%, CS = 51.9%, p < .001). There were no group differences in self-reported cigarettes/day, total nicotine equivalents, or breath carbon monoxide, but cousers had greater use of non-cigarette tobacco products. Compared to CS, cousers had higher concentrations of 3-hydroxypropylmercapturic acid, 2-cyanoethylmercapturic acid, S-phenylmercapturic acid, 3-hydroxy-1-methylpropylmercapturic acid (ps < .05), and phenanthrene tetraol (p < .001). No biomarkers were affected by number of cannabis use days/week or days since last cannabis use during baseline (ps > .05). Cousers had higher concentrations of biomarkers of exposure than CS, but similar number of cigarettes per day and nicotine exposure. Additional studies are needed to determine whether cannabis and/or alternative tobacco products are driving the increased toxicant exposure. Cousers of cannabis and tobacco appear to be exposed to greater levels of harmful chemicals (ie, volatile organic compounds and polycyclic aromatic hydrocarbons), but similar levels of nicotine as CS. It is unclear if the higher levels of toxicant exposure in cousers are due to cannabis use or the increased use of alternative tobacco products compared with CS. It is important for studies examining biomarkers of exposure among CS to account for cannabis use as it may have a significant impact on outcomes. Additionally, further research is needed examining exposure to harmful chemicals among cannabis users.

Identifiants

pubmed: 31616939
pii: 5588200
doi: 10.1093/ntr/ntz199
pmc: PMC7366295
doi:

Substances chimiques

Biomarkers 0
Polycyclic Aromatic Hydrocarbons 0
Volatile Organic Compounds 0
Carbon Monoxide 7U1EE4V452

Types de publication

Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1383-1389

Subventions

Organisme : NCI NIH HHS
ID : P30 CA077598
Pays : United States
Organisme : NIDA NIH HHS
ID : K01 DA043413
Pays : United States
Organisme : NIDA NIH HHS
ID : T32 DA007097
Pays : United States
Organisme : NIDA NIH HHS
ID : U54 DA031659
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA016351
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA027232
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002494
Pays : United States

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Chem Res Toxicol. 2008 Feb;21(2):494-502
pubmed: 18062674
Chem Res Toxicol. 2018 Aug 20;31(8):643-645
pubmed: 30052028
Chem Res Toxicol. 2009 Apr;22(4):734-41
pubmed: 19317515
Occup Environ Med. 1995 Sep;52(9):611-20
pubmed: 7550802
J Pharmacol Exp Ther. 2011 Jul;338(1):353-61
pubmed: 21515812
Mol Nutr Food Res. 2012 Dec;56(12):1825-37
pubmed: 23109489
Br J Addict. 1991 Sep;86(9):1119-27
pubmed: 1932883
Tob Control. 2017 Mar;26(e1):e61-e67
pubmed: 27924008
J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Sep 15;935:36-40
pubmed: 23934173
Drug Alcohol Depend. 2016 Sep 01;166:6-12
pubmed: 27476751
Cancer Epidemiol Biomarkers Prev. 2019 May;28(5):943-953
pubmed: 30733305
JAMA. 2018 Sep 4;320(9):880-891
pubmed: 30193275
Food Chem Toxicol. 2017 Aug;106(Pt A):147-154
pubmed: 28528972
Chem Res Toxicol. 2012 Apr 16;25(4):794-810
pubmed: 22352345
Psychol Addict Behav. 2014 Mar;28(1):154-62
pubmed: 23276315
Drug Alcohol Depend. 2018 Oct 1;191:355-360
pubmed: 30179761
Environ Int. 2016 Mar;88:1-8
pubmed: 26690539
Cardiovasc Toxicol. 2017 Jul;17(3):227-236
pubmed: 28084565
J Neuroimmune Pharmacol. 2016 Sep;11(3):471-83
pubmed: 26872457
Am J Public Health. 2018 Jan;108(1):137-142
pubmed: 29161058
Chem Res Toxicol. 2013 Aug 19;26(8):1209-17
pubmed: 23837805

Auteurs

Ellen Meier (E)

Department of Psychology, University of Wisconsin-Stevens Point, Stevens Point, WI.

Ryan Vandrey (R)

Johns Hopkins University School of Medicine, Baltimore, MD.

Nathan Rubin (N)

University of Minnesota Masonic Cancer Center, Minneapolis, MN.

Lauren R Pacek (LR)

Department of Psychiatry, Duke University School of Medicine, Durham, NC.

Joni A Jensen (JA)

University of Minnesota, Tobacco Research Programs, Minneapolis, MN.

Eric C Donny (EC)

Department of Physiology and Pharmacology, Wake Forest School of Medicine, Winston-Salem, NC.

Stephen S Hecht (SS)

University of Minnesota Masonic Cancer Center, Minneapolis, MN.

Steven G Carmella (SG)

University of Minnesota Masonic Cancer Center, Minneapolis, MN.

Sharon E Murphy (SE)

University of Minnesota Masonic Cancer Center, Minneapolis, MN.

Xianghua Luo (X)

University of Minnesota Masonic Cancer Center, Minneapolis, MN.
Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN 55414.

Irina Stepanov (I)

University of Minnesota Masonic Cancer Center, Minneapolis, MN.
University of Minnesota, Tobacco Research Programs, Minneapolis, MN.

Joshua Ikuemonisan (J)

University of Minnesota Masonic Cancer Center, Minneapolis, MN.

Herb Severson (H)

Oregon Research Institute, Eugene, OR, Duluth, MN.

Mustafa Al'absi (M)

Department of Family Medicine and BioBehavioral Health, University of Minnesota Medical School, Duluth, MN.

Dorothy K Hatsukami (DK)

University of Minnesota, Tobacco Research Programs, Minneapolis, MN.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH